Evidence map›Paper›PMID 38173734›Full record

ArticleTurkish journal of chemistry2023

Electrochemical DNA biosensors developed for the monitoring of biointeractions with drugs: a review.

Arzum Erdem, Huseyin Şentürk, Esma Yildiz, Meltem Maral, Ayla Yildirim, Aysen Bozoğlu, Burak Kivrak, Neslihan Ceren Ay

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Arzum ErdemAnalytical Chemistry Department, Faculty of Pharmacy, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-4375-8386
Huseyin ŞentürkAnalytical Chemistry Department, Faculty of Pharmacy, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-3268-8319
Esma YildizAnalytical Chemistry Department, Faculty of Pharmacy, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-8094-8277
Meltem MaralAnalytical Chemistry Department, Faculty of Pharmacy, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-0306-2181
Ayla YildirimAnalytical Chemistry Department, Faculty of Pharmacy, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0009-0002-4091-5224
Aysen BozoğluAnalytical Chemistry Department, Faculty of Pharmacy, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0009-0000-4079-1394
Burak KivrakAnalytical Chemistry Department, Faculty of Pharmacy, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0009-0004-5630-6532
Neslihan Ceren AyAnalytical Chemistry Department, Faculty of Pharmacy, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0009-0002-0614-8180
Czech Academy of Sciences, Institute of Analytical Chemistry · CZEge University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction of drugs with DNA is important for the discovery of novel drug molecules and for understanding the therapeutic effects of drugs as well as the monitoring of side effects. For this reason, many studies have been carried out to investigate the interactions of drugs with nucleic acids. In recent years, a large number of studies have been performed to electrochemically detect drug-DNA interactions. The fast, sensitive, and accurate results of electrochemical techniques have resulted in a leading role for their implementation in this field. By means of electrochemical techniques, it is possible not only to demonstrate drug-DNA interactions but also to quantitatively analyze drugs. In this context, electrochemical biosensors for drug-DNA interactions have been examined under different headings including anticancer, antiviral, antibiotic, and central nervous system drugs as well as DNA-targeted drugs. An overview of the studies related to electrochemical DNA biosensors developed for the detection of drug-DNA interactions that were reported in the last two decades in the literature is presented herein along with their applications and they are discussed together with their future perspectives.

Indexed as

anticancer drugDNA biosensordrug-DNA interactionElectrochemical biosensorintercalation

Identifiers

PMID38173734
PMCPMC10760829
OpenAlexW4388219424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.